Xtant Medical Holdings (XTNT) FCF Margin Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Xtant Medical Holdings | 64.46 Mn | 47.14 Mn | 17.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,476.00 |
| Jun 30, 2025 | 449.00 |
| Mar 31, 2025 | 1,412.00 |
| Dec 31, 2024 | 323.00 |
| Sep 30, 2024 | -422.00 |
| Jun 30, 2024 | -2,144.00 |
| Mar 31, 2024 | -2,553.00 |
| Dec 31, 2023 | -1,356.00 |
| Sep 30, 2023 | -960.00 |
| Jun 30, 2023 | -1,425.00 |
| Mar 31, 2023 | -1,563.00 |
| Dec 31, 2022 | -1,956.00 |
| Sep 30, 2022 | -1,366.00 |
| Jun 30, 2022 | 709.00 |
| Mar 31, 2022 | -1,207.00 |
| Dec 31, 2021 | 1,247.00 |
| Sep 30, 2021 | 1,054.00 |
| Jun 30, 2021 | 6,037.00 |
| Mar 31, 2021 | -672.00 |
| Dec 31, 2020 | 1,048.00 |
| Sep 30, 2020 | 2,783.00 |
| Jun 30, 2020 | 1,863.00 |
| Mar 31, 2020 | 853.00 |
| Dec 31, 2019 | 2,028.00 |
| Sep 30, 2019 | 720.00 |
| Jun 30, 2019 | 2,255.00 |
| Mar 31, 2019 | 2,729.00 |
| Dec 31, 2018 | 559.00 |
| Sep 30, 2018 | 1,440.00 |
| Jun 30, 2018 | 1,665.00 |
| Mar 31, 2018 | 3,260.00 |
| Dec 31, 2017 | 4,665.00 |
| Sep 30, 2017 | 3,395.00 |
| Jun 30, 2017 | 2,102.00 |
| Mar 31, 2017 | 4,287.00 |
| Dec 31, 2016 | 94.00 |
| Sep 30, 2016 | 965.00 |
| Jun 30, 2016 | -861.00 |
| Mar 31, 2016 | 2,167.00 |
| Dec 31, 2015 | 4,929.00 |
| Sep 30, 2015 | 2,331.00 |